Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (161-170 of 403) with videos related to

Pageof 41
Sort By:
The Journal of Infection|February 14, 2025
Risk of invasive meningococcal disease in people with sickle cell disease: A systematic reviewCatherine Isitt, Helen Campbell, Catherine A Cosgrove, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2007
Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in EnglandCaroline Trotter, Jamie Findlow, Paul Balmer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 13, 2014
Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and WalesShamez N Ladhani, Kazim Beebeejaun, Jay Lucidarme, et al.
Plos One|March 10, 2016
HPV Serology Testing Confirms High HPV Immunisation Coverage in EnglandDavid Mesher, Elaine Stanford, Joanne White, et al.
Expert Review of Vaccines|August 25, 2023
Use of expanded <i>Neisseria meningitidis</i> serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectivenessRay Borrow, Federico Martinón-Torres, Véronique Abitbol, et al.
Vaccine|April 3, 2026
Ability of the MenB-fHbp vaccine to provide immune protection against meningococcal serogroup B ST-1161 UK university "South West Outbreak" strain isolatesJay Lucidarme, Stephen A Clark, Ray Borrow, et al.
Clinical and Vaccine Immunology : CVI|April 11, 2006
Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccineHelen Findlow, Jo Southern, Lesley Mabey, et al.
Vaccine|April 17, 2013
Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)Julie A Bettinger, David W Scheifele, Scott A Halperin, et al.
Vaccine|August 24, 2025
Understanding the immunity gap for serogroup B invasive meningococcal disease due to non-pharmaceutical interventions during the Covid-19 pandemicJennifer Louth, Ann Holland, Chloe Chum, et al.
The Lancet. Child & Adolescent Health|February 3, 2023
Outcomes of meningococcal serogroup B disease in children after implementation of routine infant 4CMenB vaccination in England: an active, prospective, national surveillance studyAnna A Mensah, Helen Campbell, Stephen A Clark, et al.
Pageof 41

Showing results (161-170 of 403) with videos related to

Sort By:
Pageof 41
The Journal of Infection|February 14, 2025
Risk of invasive meningococcal disease in people with sickle cell disease: A systematic reviewCatherine Isitt, Helen Campbell, Catherine A Cosgrove, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2007
Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in EnglandCaroline Trotter, Jamie Findlow, Paul Balmer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 13, 2014
Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and WalesShamez N Ladhani, Kazim Beebeejaun, Jay Lucidarme, et al.
Plos One|March 10, 2016
HPV Serology Testing Confirms High HPV Immunisation Coverage in EnglandDavid Mesher, Elaine Stanford, Joanne White, et al.
Expert Review of Vaccines|August 25, 2023
Use of expanded <i>Neisseria meningitidis</i> serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectivenessRay Borrow, Federico Martinón-Torres, Véronique Abitbol, et al.
Vaccine|April 3, 2026
Ability of the MenB-fHbp vaccine to provide immune protection against meningococcal serogroup B ST-1161 UK university "South West Outbreak" strain isolatesJay Lucidarme, Stephen A Clark, Ray Borrow, et al.
Clinical and Vaccine Immunology : CVI|April 11, 2006
Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccineHelen Findlow, Jo Southern, Lesley Mabey, et al.
Vaccine|April 17, 2013
Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)Julie A Bettinger, David W Scheifele, Scott A Halperin, et al.
Vaccine|August 24, 2025
Understanding the immunity gap for serogroup B invasive meningococcal disease due to non-pharmaceutical interventions during the Covid-19 pandemicJennifer Louth, Ann Holland, Chloe Chum, et al.
The Lancet. Child & Adolescent Health|February 3, 2023
Outcomes of meningococcal serogroup B disease in children after implementation of routine infant 4CMenB vaccination in England: an active, prospective, national surveillance studyAnna A Mensah, Helen Campbell, Stephen A Clark, et al.
Pageof 41